Phancy Group Co., Ltd. Announces Proposed H Share Full Circulation
Key Highlights for Investors
- Phancy Group Co., Ltd. (Stock Code: 6682), formerly known as Beijing Fourth Paradigm Technology Co., Ltd., has announced a major development regarding its share capital structure.
- The company is proposing to implement a full circulation of H shares, converting 53,157,667 domestic unlisted shares into H shares.
- These shares represent approximately 9.52% of the company’s total issued share capital as of the date of the announcement.
- The converted H shares will be listed and traded on the Main Board of the Hong Kong Stock Exchange, subject to regulatory approval and filing.
- No shareholders’ meeting is required for this action, as per the company’s Articles of Association and relevant PRC laws.
Details and Implications
The Board of Directors has approved the proposed conversion of domestic unlisted shares personally held by the controlling shareholder and other shareholders into H shares. This move follows the latest guidelines from the China Securities Regulatory Commission (CSRC) for the “full circulation” of domestic unlisted shares by H-share companies.
The company has already submitted the required application and filing documents to the CSRC. Upon receiving all necessary approvals from both the CSRC and the Hong Kong Stock Exchange, the company will apply for the listing and permission to deal in these newly converted H shares.
The company will keep investors updated with further announcements regarding the progress of this process, in line with the Hong Kong Listing Rules and Inside Information Provisions.
Why This Matters to Shareholders and Potential Impact on Share Price
- Potential Increase in Liquidity: The conversion of almost 10% of the company’s share capital into H shares could significantly increase the liquidity of Phancy’s shares on the Hong Kong Stock Exchange.
- Possible Share Price Volatility: The increased supply of tradable shares may lead to short-term fluctuations in share price, depending on market sentiment and investor response.
- Regulatory Uncertainties: The process is subject to approval by the CSRC, the Hong Kong Stock Exchange, and other regulatory authorities, and there is no guarantee of approval or timeline certainty.
- No Shareholders’ Meeting Required: Investors should note that this major share conversion does not require a shareholders’ meeting, meaning there’s no shareholder vote on the matter.
The company specifically advises shareholders and potential investors to exercise caution when dealing in its securities during this period of regulatory review and pending approval.
Leadership and Governance
The Board of Directors comprises Dr. Dai Wenyuan (Chairman and Executive Director), Mr. Chen Yuqiang (Executive Director), Dr. Yang Qiang, Mr. Dou Shuai, and Mr. Zhang Jing (Non-executive Directors), Mr. Li Jianbin, Mr. Liu Chijin, Ms. Ke Yele, and Mr. Pan Jialin (Independent Non-executive Directors), and Mr. Chai Yifei (Employee Representative Director).
What’s Next?
Investors should monitor company announcements for further updates on the H Share Full Circulation process and be aware of the potential impact on share price resulting from increased share availability and regulatory developments.
Disclaimer
The above article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult professional advisors before making any investment decisions. The information is based on the company’s public disclosure as of June 2, 2026, and may be subject to change.
Phancy Group Co., Ltd. 公佈建議實施H股全流通
投資者重點摘要
- Phancy Group Co., Ltd.（股份代號：6682），前稱北京第四範式科技股份有限公司，宣佈有關其股份結構的重要新進展。
- 公司建議實行H股全流通，將53,157,667股境內未上市股份轉換為H股。
- 有關股份佔公司截至公告日期已發行總股本約9.52%。
- 轉換後的H股將於香港聯合交易所主板上市及買賣，須經監管部門批准及備案。
- 根據公司章程及中國法律，本次行動無需召開股東大會批准。
詳情及影響
董事會已批准將由控股股東及其他股東個人持有的境內未上市股份轉換為H股。此舉遵循中國證監會（CSRC）最新發佈的關於H股公司「全流通」的指引。
公司已向中國證監會提交所需申請及備案文件。獲得中國證監會及香港聯交所所有必要批准後，公司將申請該批新H股上市及買賣許可。
公司將根據上市規則及內幕消息條款，適時公佈有關H股全流通及上市進展，請投資者密切留意。
股東須知及潛在股價影響
- 流動性提升： 近一成股本轉為H股，有望大幅提升公司於香港市場的股份流動性。
- 股價波動風險： 可買賣股份增加或引致短期股價波動，具體則視乎市場情緒及投資者反應。
- 監管不確定性： 全流通及上市事宜須中國證監會、香港聯交所及其他監管機構審批，時間及最終能否獲批具不確定性。
- 無需股東大會： 投資者需留意，該重大股份轉換無需股東會表決。
公司特別提示股東及潛在投資者，在相關監管審批期內買賣公司證券時應保持審慎。
公司管理層及管治
董事會成員包括：董事長兼執行董事戴文淵博士、執行董事陳宇強先生、非執行董事楊強博士、竇帥先生、張靖先生、獨立非執行董事李建斌先生、劉馳錦先生、柯葉樂女士、潘家林先生，以及員工代表董事柴一飛先生。
後續動向
投資者應留意公司進一步公告，關注H股全流通進程及由於股份可流通量增加和監管變化帶來的潛在股價影響。
免責聲明
以上資訊僅供參考，並不構成任何投資建議。投資者應自行研究或諮詢專業顧問後再作投資決定。內容以公司2026年6月2日公開披露為準，日後或有變更。
